Buys
Open market- Shares
- +9,698
- Avg price
- $11.79
- Total value
- +$114,292
Daniel R. Chevallard - Chief Financial Officer at LENZ Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- LENZ on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Daniel R. Chevallard in LENZ Therapeutics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +9,698
- Share %
- 100%
- Total value
- +$114,292
Reported holdings for Daniel R. Chevallard in LENZ Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
LENZ Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 12,886
- Estimated value
- $110,433
- Report date
- 27 Mar 2026
- Price
- $8.57
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
LENZ Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 84,200
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
LENZ Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 14,000
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Daniel R. Chevallard in LENZ Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.